MSOS:NYE-AdvisorShares Pure US Cannabis ETF (USD)

ETF | Others |

Last Closing

USD 3.68

Change

+0.02 (+0.55)%

Market Cap

USD 0.53B

Volume

1.72M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.15 (-0.79%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.43 (+0.74%)

USD 37.61B
DFAC Dimensional U.S. Core Equity 2..

+0.30 (+0.86%)

USD 33.40B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 28.50B
JPST JPMorgan Ultra-Short Income ET..

+0.01 (+0.02%)

USD 28.13B
DTB DTE Energy Company 2020 Series

-0.19 (-0.99%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

+4.74 (+6.43%)

USD 21.47B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 16.06B
AVUV Avantis® U.S. Small Cap Value..

+0.99 (+1.03%)

USD 15.95B
DFUS Dimensional U.S. Equity ETF

+0.69 (+1.07%)

USD 13.15B

ETFs Containing MSOS

YOLO AdvisorShares Pure Cannab.. 34.63 % 0.00 %

+0.02 (+0%)

USD 0.03B
BUDX 23.56 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -47.50% 2% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -47.50% 1% F 4% F
Trailing 12 Months  
Capital Gain -48.53% 2% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.53% 2% F 4% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -21.88% 1% F 2% F
Dividend Return -21.88% 1% F 2% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41.56% 6% D- 24% F
Risk Adjusted Return -52.66% 5% F 4% F
Market Capitalization 0.53B 83% B 49% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.